Anavex Life Sciences Corp (AVXL)

[McMagyar]

I asked Anavex IR why a 5 week test point was chosen after 52 weeks?
So Anavex did 52 week data sample from start of Phase 2a and then a..

"This is a close-out, end of PART B visit."

Logically 52 weeks of Part A has no scientific value as there was a week clean out and changing dosing and you were getting another reading in 5 weeks. also at 5 week and 31 week report nowhere does it show a 47 week testpoint for PART B..

For some reason they took an extra Patient Reading..

It was during the duration of PART B..NOT during PART C as
I incorrectly guessed in one post..